BCL2 and synovial sarcoma: One hypothesis is that the increased susceptibility of malignant cells may be related to changes involving the antiapoptotic protein Bcl-2, which has been found to be overexpressed in MF and SS [23], although subsets of patients lacking Bcl-2 have been reported [24].